ARCHIVES

Funding Opportunities.

This article is from The Cancer Letter archive.

Vol. 28 No. 22 | May 31, 2002

Download PDF Visit The Full Archive

Related Articles

Early Clinical Trials Of Targeted Therapies Highlighted At AACR-NCI-EORTC Meeting

October 26, 2007

ODAC Recommends Approval Of Nplate For Thrombocytopenia.

March 21, 2008

DCT Board Approves Recompetition Of Drug Development Contracts

June 25, 1993

House Passes Cancer Act Renewal With Provision Permitting NCI To Reinstate Training Program

May 10, 1974

IOM Report: Seek More Comment From Public On Priorities, NIH Told

July 17, 1998

Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors.

June 17, 2005